Avanos Medical (AVNS) Accounts Payables (2013 - 2026)

Avanos Medical has disclosed Accounts Payables across 14 years of filings, most recently posting $52.3 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $52.3 million, up 13.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.3 million (up 13.7% YoY), and the FY2025 annual result was $55.5 million, up 2.21% from the prior year.
• Accounts Payables came in at $52.3 million for Q1 2026 at Avanos Medical, down from $55.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $67.9 million in Q4 2022 to a low of $46.0 million in Q1 2025.
• The 5-year median for Accounts Payables is $55.5 million (2025), against an average of $56.8 million.
• Across the five-year window, Accounts Payables grew 20.39% in 2022 and retreated 21.41% in 2024, its largest moves.
• Avanos Medical's Accounts Payables stood at $67.9 million in 2022, then decreased by 17.08% to $56.3 million in 2023, then fell by 3.55% to $54.3 million in 2024, then rose by 2.21% to $55.5 million in 2025, then dropped by 5.77% to $52.3 million in 2026.
• The last three Accounts Payables figures came in at $52.3 million (Q1 2026), $55.5 million (Q4 2025), and $54.2 million (Q3 2025), per Business Quant data.